Plasma and cerebrospinal fluid homocysteine, nitric oxide and malondialdehyde levels in acute ischemic stroke: Possible role of free radicals in the development of brain injury

European Journal of General Medicine

Volumn 5, Issue 2, 2008, Pages 57-63

  Aygül, Recep ^a   Kotan, Dilcan ^a   Yildirim, Abdulkadir ^a   Ulvi, Hizir ^a   Akçay, Fatih ^a  

^a ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Homocysteine; Ischemic stroke; Malondialdehyde; Nitric oxide; Oxidative brain injury

Indexed keywords

HOMOCYSTEINE; MALONALDEHYDE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BRAIN INJURY; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GENDER; GLASGOW COMA SCALE; HUMAN; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 55849139391     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82578     Document Type: Article

References (40)

1. De Freitas GR, Bogousslavsky J. Primary stroke prevention. Eur J Neurol 2001;8:1-15
2. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29:415-21
3. Sudlow CL and Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 1997;28:491-99
4. Fisher M and Schaebitz W. An overview of acute stroke therapy. Past, present, and future. Arch Intern Med 2000;160:3196-206
5. Love S. Oxidative stress in brain ischaemia. Brain Pathol 1999;9:119-31
6. nd Virtual Congress of Cardiology - FAC, Argentina, Sep 1-Nov 30,2001
7. Re G, Azzimondi G, Lanzarini C, Bassein L, Vaona I, Guarnieri C. Plasma lipoperoxidative markers in ischemic stroke suggest brain embolism. Eur J Emerg Med 1997;4:5-9
8. El-Kossi MMH, Zakhary MM. Oxidative Stress in the context of acute cerebrovascular stroke. Stroke 2000;31:1889-97
9. Warner DS, Sheng H, Haberle IB. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004;207:3221-31
10. Chabrier PE, Auguet M, Spinnewyn B, et al.BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci USA 1999;96:10824-29
11. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI. Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 2000;31:1069-75
12. Giles WH, Croft JB, Greenlund KJ, et al. Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998;29:2473-77
13. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999;131:352-55
14. Chao CL, Lee YT. Impairment of cerebrovascular reactivity by methione-induced hyperhomocysteinemia and amelioration by quinapril treatment. Stroke 2000;31:2907-11
15. Thambyrajah J, Townend JN. Homocysteine and atherothrombosis - mechanisms for injury. Eur Heart J 2000;21:967-74
16. Rosengarten B, Osthaus S, Auch D, Kaps M. Effects of acute hyperhomocysteinemia on the neurovascular coupling mechanism in healthy young adults. Stroke 2003;34:446-51
17. Misra HP. Generation of superoxide free radical during the autooxidation of thiols. J Biol Chem 1974;249:2151-55
18. Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 1994;105:165-70
19. Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004;35:345-47
20. Heinecke JW, Rosen H, Suzuki LA, Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low-density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987;262:10098-103
21. Teasdale G, Jenett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81-3
22. Jenett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet 1975;1:480-4
23. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993;39:263-71
24. Slater TF: Overview of methods used for detecting lipid peroxidation. Methods Enzimol 1984;105:283-93
25. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995;41:892-96
26. Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol 2001;8:43-8
27. Sharp PC, Mulholland C, Trinic KT. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994;163:488-91
28. Selakovic VM, Jovanovic MD, Jovicic A. Changes of cortisol levels and index of lipid peroxidation in cerebrospinal fluid of patients in the acute phase of completed stroke. Vojno Pregl 2002;59:485-91
29. Watson BD. Evaluation of concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke. Prog Brain Res 1993;96:69-95
30. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-23
31. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 1994;28:221-67
32. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 2000;301:173-87
33. Castillo J, Rama R, Dávalos A. Nitric Oxide-Related brain damage in acute ischemic stroke. Stroke 2000;31:852-58
34. Shankar R, Zhu J-S, Ladd B, Henry D, Shen H-Q, Baron AD. Central Nervous System Nitric Oxide Synthase Activity Regulates Insulin Secretion and Insulin Action. J Clin Invest 1998;102:1403-12
35. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9
36. Serot JM, Béné MC, Faure GC. CSF homocysteine, CSF folates and choroid plexus. Neurobiol Aging 2003;24:627-8
37. Jia L, Furchgott RF. Inhibition by sulphydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor. J Pharmacol Exp Ther 1993;267:371-8
38. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996;98:24-9
39. Zhang F, Slungaarg A, Vercellotti GM, Iadecola C. Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol 1998;274:1704-11
40. Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF. Changes in plasma homocysteine in the acute phase after stroke. Stroke 2002;33:473-78